Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
Fuji Pharma Co.,Ltd. 4554
| Cost of capital | no mention mentions it only outside the narrative | matched by rule |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | names a metric 「収益性改善に伴い、EBITDARは106億円から230億円と倍増させ、営業利益ベースの一株あたり純利益は240円、ROEは10%を目標としております」BusinessPolicyBusinessEnvironmentIssuesToAddressEtcTextBlock | matched by rule |
| Target | target without a date 「収益性改善に伴い、EBITDARは106億円から230億円と倍増させ、営業利益ベースの一株あたり純利益は240円、ROEは10%を目標としております」BusinessPolicyBusinessEnvironmentIssuesToAddressEtcTextBlock | matched by rule |
| Payout | states a numeric policy 「今後の配当は、業績に応じて増配また維持とし、特別要因を除いた配当性向30%以上を継続して参ります」DividendPolicyTextBlock | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names